Halima Bello-Manga MBBS; MPH
Department of Hematology and Blood Transfusion Barau Dikko Teaching Hospital/Kaduna State University, Kaduna, Nigeria.
Dr Halima Bello-Manga is a board-certified Hematologist and Senior Lecturer (working at Barau Dikko Teaching Hospital/Kaduna State University, Nigeria. She has devoted her clinical and research career to the care of children and adults with hematologic conditions, with emphasis on sickle cell disease (SCD). She is committed to improving the clinical outcomes of children with SCD in Nigeria and globally, particularly in preventing strokes, a devastating complication of SCD.
She served as a site investigator for the NIH-funded multi-center randomized trial on primary stroke prevention in children with sickle cell anemia in Nigeria (SPRING trial). Following the successful completion of the SPRING trial, she established a stroke prevention program for children with SCD at BDTH, an academic hospital. She is currently funded through the Fogarty Emerging Global Leader Award (K43) to establish a similar program at a Community Hospital in Kaduna, Nigeria. Dr Bello-Manga has attended the Vanderbilt Institute of Research Development and Ethics (2017 and 2019) and the American Society of Hematology’s Clinical Research Training Institute (2019). She serves as a Principal Investigator on several SCD-related clinical trials including; HOPE Kids2, RESOLVE and THRIVE trials.
